Modeling & Simulation Reshaping Regulatory Science | 모델링 및 시뮬레이션, 규제 과학을 재편하다
Modeling & simulation are revolutionizing drug development & regulatory science, offering faster, cheaper, and more reliable results.
국내외 이슈들
Modeling & simulation are revolutionizing drug development & regulatory science, offering faster, cheaper, and more reliable results.
OpenAI is reportedly acquiring Jony Ive’s hardware company, signaling a move into AI-powered hardware development.
The US economy expanded at a robust 4.3% in Q3, exceeding expectations and signaling resilience amidst global economic uncertainties.
Korea cracks down on policy fund ‘brokers,’ raising concerns about startup capital access. Will this improve integrity or hinder innovation?
Expert insights on the AI trends shaping 2026 and how leaders can adapt to maintain a competitive edge in the rapidly evolving landscape.
Harvard researchers developed an AI tool to pinpoint gene-drug combos that restore health in diseased cells, offering new avenues for treatment.
Bloomberg reports consumer AI gadgets face a muted launch due to high costs, limited usefulness, and privacy concerns, hindering widespread adoption.
The U.S. economy shows surprising strength with a 4.3% growth rate, but high inflation remains a persistent challenge.
Fortune reports on Startup Stuffers’ pre-teen founders demonstrating impressive AI utilization skills, offering valuable lessons for businesses.
A new study reveals that a significant portion of UK citizens are turning to AI for emotional support, raising questions about the future of mental well-being.